Skip to content

Medical Cannabis and Breast Cancer

Medical Cannabis and Breast Cancer

October is breast cancer awareness month and we at Arfinn Med would like to reiterate the importance of early screening and regular tests.  According to the American Cancer Society:

“Breast cancer is the most common cancer in American women, except for skin cancers. Currently, the average risk of a woman in the United States developing breast cancer sometime in her life is about 13%. This means there is a 1 in 8 chance she will develop breast cancer. This also means there is a 7 in 8 chance she will never have the disease.”

Though more studies are needed, we wanted to share some current research about medical marijuana and how it can possibly help breast cancer patients.

According to Virginia F. Borges, M.D., MMSc., professor of medicine and director of the Breast Cancer Research Program at the University of Colorado Cancer Center, she finds that cannabis can help improve some of the symptoms associated the breast cancer treatment.

“I’ve mainly seen it used in conjunction with prescription drugs to control pain and other side effects in patients living with metastatic disease,” she said. “It’s rare that a person living with metastatic breast cancer would have only one side effect to manage. So, by adding in medical marijuana, it often allows me to cut back on the number of drugs I prescribe. With a high-quality source for medical marijuana and knowing how it affects an individual, using medical marijuana can put more control back in the hands of my patient. If someone is feeling good, she may only need to take one or two drops per day. If she’s not feeling good, she may need three or four drops per day. Many of the prescription drugs don’t have this flexibility. Any time you can give control back to a person when their living with cancer, it’s a good thing.”

In addition to helping with the side effects of treatment, some research has shown the ability for cannabidiol (CBD) to actually treat breast cancer itself.  A study published in the journal Molecular Cancer Therapeutics found CBD to be very helpful in inhibiting aggressive cancer cells.

“In the study the team led by senior scientist Dr. Sean D. McAllister used CBD to inhibit the activity of the Id-1 gene, believed to be responsible for cancer cells becoming more aggressive and metastatic. “Metastasis is the final and fatal step in the progression of breast cancer,” the authors write. “Currently available therapeutic strategies at this stage of cancer progression are often nonspecific, have only marginal efficacy and are highly toxic.”

Though cannabinoid medicine has been shown to help with some aspects of breast cancer and the resulting treatment side effects, more research is needed to truly understand its role in the recovery of breast cancer patients.  We hope that as the stigma of medical marijuana disappears, research will be easier to conduct.

In the meantime, please get regular screenings and encourage others to do as well!

Resources:

https://www.breastcancer.org/treatment/comp_med/types/medical-marijuana

https://health.usnews.com/health-care/patient-advice/articles/2017-09-05/can-marijuana-help-with-breast-cancer

https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html

Stories you may be interested in

COVID-19 and medical cannabis patients: What you need to know

In the midst of the COVID-19 maelstrom, the recent shuttering of nonessential stores has created concern around access to cannabis, particularly for medicinal cannabis consumers. Those who depend on cannabis for therapeutic purposes will be relieved to learn that across the US, medical cannabis dispensaries have been deemed essential services, comparable to pharmacies. As of March…
Read More

New Feature: Calendar Integration

At Arfinn Med, we’re excited to announce the third feature update to join automated text messaging and note templating: calendar integration. With this addition, physicians can now integrate their Google Calendar or Calendy account. The implementation of calendar integration rounds out the Arfinn Med portal, making it a physician’s one-stop-shop EMR tool. How It Works…
Read More

World Cancer Day – Shine a Light on the World

In 2018, it was estimated that 1,735,350 new cancer cases would be diagnosed in the United States and 609,640 individuals would pass from the disease [Cancer.gov]. We cannot sit by and ignore this life altering disease, which is why World Cancer Day, recognized on Feb. 4, is such an important awareness campaign to the Arfinn…
Read More

Study on cannabis chemical as a treatment for pancreatic cancer may have ‘major impact,’ Harvard researcher says

Pancreatic cancer makes up just 3 percent of all cancers in America. But with a one-year survival rate of just 20 percent (and five-year survival rate of less than 8), it’s predicted to be the second leading cause of cancer-related death by 2020. Headlines about the illness, as a result, tend to be discouraging. But this month scientists from Harvard University’s Dana-Farber…
Read More

Cannabis and Seniors

As more and more research comes out regarding the medical benefits of cannabis, it’s important to keep up with new research as it becomes available.  Here at Arfinn Med, we constantly review new studies and look at our own deidentified efficacy data to try to find any additional insights we can relay to our registered…
Read More

PTSD and Cannabis

Post-Traumatic Stress Disorder (PTSD) is a psychiatric disorder that occurs in people who witnessed or have gone through a traumatic event.  That can include events such as  natural disasters, war/combat, a serious accident, or personal assault, among others.  People suffering from PTSD have disturbing thoughts and feelings related to the traumatic event that can last…
Read More

Leave a Comment

You must be logged in to post a comment.